Research and Development

A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …

In part one, we looked at the difficulty in recruiting and retaining patients for clinical trials, and how increased communication …

Pfizer is celebrating the approval by the European Union of its breast cancer drug Ibrance, following a positive recommendation from …

Novavax released the news that it would cut away 30% of its workforce alongside third quarter results that revenues were …

The China Food and Drug Administration (CFDA) has released a new app earlier this week which enables users to download …

Janssen, part of Johnson & Johnson, released details on 9 November of the results of a new study looking into …

Pfizer has announced that it will close two of the three manufacturing plants it still holds in the UK. The …

Amgen has seen its drug Kyprolis (carfilzomib) rejected by NICE for its routine use in the treatment of multiple myeloma …

It’s easy to say that Valeant hasn’t had a great year so far. Unfortunately for those concerned, the outlook for …

BenevolentAI, a British artificial intelligence company, announced a licensing agreement to develop a select number of drug candidates with Janssen, …

vasopharma, a privately held biopharmaceutical company, announced on 8 November that it had appointed Irina Antonijevic as their chief medical …

There is only one more day to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …

Biogen and Ionis Pharmaceuticals have released news that their investigational treatment for spinal muscular atrophy (SMA), Spinraza (nusinersen), met the …

There are only two more days to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …

The pharmaceutical industry has a big problem and it’s one that keeps getting worse every year – how to stop …